StonvexLoading…
StonvexStonvexStonvexCore line items from KRYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $116.36M | $389.13M | $282.02M | $184.22M |
Operating Income | $53.69M | $161.29M | $117.03M | $75.48M |
Net Income | $55.93M | $204.83M | $153.43M | $38.33M |
EPS (Diluted) | $1.83 | $6.84 | $5.14 | $2.48 |
Total Assets | $1.40B | $1.33B | $1.24B | $1.14B |
Total Liabilities | $120.24M | $114.23M | $102.22M | $97.75M |
Cash & Equivalents | $501.31M | $496.30M | $392.60M | $353.83M |
Free Cash Flow OCF − CapEx | $73.23M | $188.91M | $113.55M | $75.59M |
Shares Outstanding | 29.44M | 29.19M | 28.98M | 28.93M |